Assistant Professor of Medicine
Weill Cornell Medicine
Dr. Michael Satlin an infectious diseases physician and Assistant Professor of Medicine at Weill Cornell Medicine. He is the Clinical Director of the Transplantation-Oncology Infectious Diseases Program at Weill Cornell. He completed medical school at the University of Virginia School of Medicine and completed internal medicine residency and fellowship training at NewYork-Presbyterian Hospital/Weill Cornell. He also obtained a Master’s Degree in Clinical and Translational Investigation at Weill Cornell. His research focuses on the epidemiology, prevention, and treatment of multidrug-resistant Gram-negative infections, with a particular focus on immunocompromised hosts. He has an R01 grant through the National Institute of Allergy and Infectious Diseases (NIAID) to investigate the role of screening for resistant enteric bacteria to personalized infection prevention strategies in neutropenic patients. He is on the Editorial Advisory Boards of Clinical Infectious Diseases and Open Forum Infectious Diseases and Associate Editor for Journal of Antimicrobial Chemotherapy-Antimicrobial Resistance. He has authored or co-authored over 65 peer-reviewed manuscripts. He is a Member of the Clinical and Laboratory Standards Institute’s (CLSI) Subcommittee on Antimicrobial Susceptibility Testing and Co-Chair of its Breakpoint Working Group. Lastly, he serves on the ASM Microbe Program Committee and is a Member of multiple committees for the NIAID’s Antibacterial Resistance Leadership Group.
Disclosure: Achaogen: Consultant; Allergan: Grant/Research Support; BIoFire Diagnostics (Individual(s) Involved: Self): Grant/Research Support; Merck: Grant/Research Support; Shionogi Inc.: Consultant
Thursday, October 22, 2020
3:45pm – 5:00pm EDT
